Showing results (391-400 of 510) with videos related to
Sort By:
Pageof 51
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.Lancet (London, England)|December 18, 2020
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trialRobert Croop, Richard B Lipton, David Kudrow, et al.Neurology|November 2, 2012
Migraine headache is present in the aura phase: a prospective studyJakob M Hansen, Richard B Lipton, David W Dodick, et al.British Journal of Pharmacology|October 2, 2021
The selective 5-HT1F receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headacheMarta Vila-Pueyo, Keith Page, Paul R Murdock, et al.Neurology|August 10, 2014
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine preventionTony W Ho, Kathryn M Connor, Ying Zhang, et al.Journal of Sleep Research|May 3, 2021
Cyclic alternating pattern in obstructive sleep apnea: A preliminary studyValentina Gnoni, Panagis Drakatos, Sean Higgins, et al.Pain and Therapy|December 7, 2021
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and MigraineChristian J Cerrada, Jae S Min, Luminita Constantin, et al.European Journal of Neurology|December 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER TrialCristina Tassorelli, Amaal J Starling, Susanne F Awad, et al.Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.Pageof 51